Stereotaxis

company

About

Stereotaxis develops robotic cardiology instrument navigation systems that enhances the treatment of arrhythmias and coronary diseases.

  • 51 - 100

Details

Last Funding Type
Series Unknown
Industries
Biotechnology,Health Care,Medical Device,Navigation
Founded date
Jan 1, 1990
Number Of Employee
51 - 100
Operating Status
Active

Stereotaxis focuses on the development of robotic cardiology instrument navigation systems designed to enhance the treatment of arrhythmias and coronary disease, as well as information management solutions for the interventional lab. With over 100 patents for use in a hospital's interventional surgical suite, Stereotaxis helps physicians around the world provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced collaboration of life-saving information.

Stereotaxis' core technologies are the Niobe® ES Remote Magnetic Navigation system, the Odyssey™ portfolio of lab optimization, networking and patient information management systems and the Vdrive™ Robotic Mechanical Navigation system and consumables.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$45M
Stereotaxis has raised a total of $45M in funding over 2 rounds. Their latest funding was raised on Aug 8, 2019 from a Post-IPO Equity round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 8, 2019 Post-IPO Equity $25M 1 Detail
Jan 10, 2003 Series Unknown $20M 1 Detail
Jul 31, 1998 Series Unknown 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
Stereotaxis is funded by 2 investors. Opaleye Management and Advantage Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Opaleye Management Post-IPO Equity
Advantage Capital Series Unknown